24/7 Patient Assistance: 760-405-8205

Kevin Kim, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Kevin Kim did his medical school at the University of Illinois College of Medicine and his internship at the VA Westside Medical Center. He did his residency in internal medicine at the Mayo School of Graduate Medical Education and his fellowship in medical oncology at the University of Texas Health Science Center. Dr. Kim is a board-certified oncologist and practices at the California Pacific Medical Center and University of Texas MD Anderson Cancer Center. He has been practicing for about 20 years and has also contributed to over 80 research papers.

  • Education & Training


    University of Illinois College of Medicine

    Medical School


    VA Westside Medical Center



    Mayo School of Graduate Medical Education



    University of Texas Health Science Center


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    California Pacific Medical Center

    Languages: English/Spanish

    (415) 600-6000

    Castro St & Duboce Ave

    San Francisco, California 94114

    Read More

    University of Texas MD Anderson Cancer Center

    Languages: English/Spanish


    1515 Holcombe Blvd

    Houston, Texas 77030

    Read More
  • Publications & Memberships

    Dr. Kevin Kim has contributed to 3 publications.

    Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.

    Hong, D. S.,Kurzrock, R.,Wheler, J. J.,Naing, A.,Falchook, G. S.,Fu, S.,Kim, K. B.,Davies, M. A.,Nguyen, L. M.,George, G. C.,Xu, L.,Shumaker, R.,Ren, M.,Mink, J.,Bedel...; Clin. Cancer Res.. 2015 Jul 15.

    See more >>

    Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma.

    Hong, D. S.,Kurzrock, R.,Falchook, G. S.,Andresen, C.,Kwak, J.,Ren, M.,Xu, L.,George, G. C.,Kim, K. B.,Nguyen, L. M.,O'Brien, J. P.,Nemunaitis, J.; Oncotarget. 2015 Oct 28.

    See more >>

    Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

    Siroy, A. E.,Boland, G. M.,Milton, D. R.,Roszik, J.,Frankian, S.,Malke, J.,Haydu, L.,Prieto, V. G.,Tetzlaff, M.,Ivan, D.,Wang, W. L.,Torres-Cabala, C.,Curry, J.,Roy-Ch...; J. Invest. Dermatol.. 2014 Aug 26.

    See more >>